Evidence map›Paper›PMID 41742209›Full record

ArticleJournal of neuroinflammation2026

Lcn2 deficiency leads to long-lasting social impairments independent of maternal immune activation.

Martyna Pekala, Sylwia Zawiślak, Sandra Romanis, Karolina Nader, Joanna Dzwonek, Aleksandra Cabaj, Anna Madecka, Alicja Puścian, Ewelina Knapska, Robert Pawlak and 2 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Martyna PekalaLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Sylwia ZawiślakLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Sandra RomanisLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Karolina NaderLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Joanna DzwonekLaboratory of Cell Biophysics, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Aleksandra CabajLaboratory of Sequencing, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Anna MadeckaLaboratory of Emotions Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Alicja PuścianLaboratory of Neuroeconomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland.
Ewelina KnapskaLaboratory of Emotions Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Robert PawlakDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, University of Exeter, Exeter, UK.
Leszek KaczmarekLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland.
Katarzyna KalitaLaboratory of Neurobiology, Nencki-EMBL Partnership for Neural Plasticity and Brain Disorders - BRAINCITY, Nencki Institute of Experimental Biology Polish Academy of Sciences, Warsaw, Poland. k.kalita@nencki.edu.pl.

Funding

Narodowym Centrum Nauki 2017/27/B/NZ4/01639 and 2022/45/B/NZ4/03262
6 · The paper itself

Abstract

Maternal infection during pregnancy is a well-established risk factor for neurodevelopmental disorders (NDDs), yet the underlying molecular mechanisms remain poorly understood. Lipocalin-2 (Lcn2), an innate immune protein, is highly upregulated during infection, known to affect neuronal and glial function. This study investigates the role of Lcn2 in shaping brain development, particularly after maternal immune activation (MIA). To mimic maternal infection, pregnant mice received intraperitoneal injections of either lipopolysaccharide (LPS) or saline on embryonic days 16 to 18 to model infection during the second trimester of pregnancy in humans. We first showed that Lcn2 mRNA was expressed in the fetal brain and that MIA significantly upregulated Lcn2 mRNA in the hippocampus and neocortex of both sexes. To assess functional relevance, we employed Lcn2 heterozygous females to generate wild-type and Lcn2 KO offspring from the MIA and control groups. Both female and male offspring underwent a battery of behavioral assays. Strikingly, both Lcn2 deletion and MIA independently led to social deficits and increased repetitive behaviors, hallmark features of NDDs, but their combination did not produce additive effects, suggesting a shared or converging mechanism. These alterations were specific to social and repetitive behavior, as no deficits were observed in the learning and memory task. To investigate potential shared molecular mechanisms, we quantified pro-inflammatory cytokine levels in the placenta and fetal forebrain at 4 h after the final LPS injection. No genotype-dependent differences were observed in IL-6, TNF-α, or IL-1β expression. However, RNA sequencing analysis revealed an overlapping group of differentially expressed genes in the Lcn2 KO and MIA groups, indicating convergence on similar transcriptional pathways that may underlie the observed behavioral phenotypes. Together, these findings reveal a previously unrecognized role for Lcn2 in brain development and suggest that while Lcn2 may not directly mediate the damaging effects of maternal immune challenge, it intersects with critical developmental pathways that shape social behavior.

Indexed as

BrainLipocalin-2Prenatal Exposure Delayed EffectsSocial BehaviorAnimalsFemaleLipopolysaccharidesMaleMiceMice, Inbred C57BLMice, KnockoutPregnancyLcn2 protein, mouseLipocalin-2LipopolysaccharidesLcn2maternal immune activationneurodevelopmental disorders

Identifiers

PMID41742209
PMCPMC13040801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.